A novel and efficient tandem CD19-and CD22-directed CAR for B cell ALL

Zanetti, SR; Velasco-Hernandez, T; Gutierrez-Aguera, F; Diaz, VM; Romecin, PA; Roca-Ho, H; Sanchez-Martinez, D; Tirado, N; Baroni, ML; Petazzi, P; Torres-Ruiz, R; Molina, O; Bataller, A; Fuster, JL; Ballerini, P; Juan, M; Jeremias, I; Bueno, C; Menendez, P

Zanetti, SR; Velasco-Hernandez, T; Menendez, P (通讯作者),Univ Barcelona, Sch Med, Josep Carreras Leukemia Res Inst, Carrer Casanova 143,4 Floor, Barcelona 08036, Spain.

MOLECULAR THERAPY, 2022; 30 (2): 550

Abstract

CD19-directed chimeric antigen receptor (CAR) T cells have yielded impressive response rates in refractory/relapse B cell acute lymphoblastic leukemia......

Full Text Link